Amino Asylum review

A familiar name, a new owner, and very little to check

The domain aminoasylumofficial.com trades as the Amino Asylum Official Site, and it opens with an unusual statement. The site says it is under new private ownership by an investment group, that it has no association with the previous owners, and that the original Amino Asylum business closed in 2025 after an FDA enforcement action with criminal charges against its founders. Secondary sources describe a June 2025 FDA raid, but we could not locate an FDA warning letter or a Department of Justice record confirming any of this, so we treat the history as the current operator’s own account. The catalog runs to about 83 listings across peptides, SARMs, pro-hormones, research oils and research chemicals, in vials, liquids, nasal and capsule formats.

For this review we read the about page, the shipping page and the third-party testing page, looked for a company name, an address, a phone number and an email, searched for an example certificate, and then compared what the site says with the public record kept by Finnrick, an independent testing aggregator, on the original vendor. The one thing to know before going further is that the relaunched storefront asks to be judged as a new company while giving a reader almost nothing to judge it by.

What the testing page claims and what it shows

The testing page makes a clear promise. Every lot, it says, carries a third-party certificate of analysis matched to the lot number printed on the label, and products are held to a purity standard of 98 percent or better by HPLC. The page also says that the company’s lab partners have been identified. That is the whole of the testing disclosure. No laboratory is named, and we could not find a single example certificate anywhere on the site, not on the testing page and not on a product page. Mass spectrometry, endotoxin and sterility testing are not mentioned at all.

A certificate that is matched to the lot number on the label is exactly the right design, and if the company published even one example a buyer could judge the laboratory, the method and the format for themselves. That leaves a buyer with a described process and no document. We record third-party testing as limited and the public certificate status as unknown, because a claim of per-lot certificates that cannot be seen is indistinguishable, from the outside, from no certificates. The site also displays an “FDA Compliance” badge and a “Third Party Lab Tested and COAs” badge. Neither is backed by a certificate or a reference number, and an FDA badge in particular is not something the agency issues to a seller of research materials.

The independent record concerns the original business rather than the new one, and we flag that distinction plainly. Finnrick tested 15 samples sold by the original Amino Asylum, the latest on March 16, 2025, and recorded 7 passes and 8 fails. BPC-157 failed both of its tests. Finnrick also notes that the samples lacked batch identifiers, which is consistent with a storefront that did not publish lot-matched certificates at the time. Whether the new operator sources from the same place is unknown, and the site gives no way to find out.

The company, the catalog and the policies

The relaunched site publishes no legal entity, no street address, no phone number and no email. It says it is US-based and gives no city. Finnrick reports that the original Amino Asylum LLC was a Kentucky company administratively dissolved in 2021, and that an earlier domain, aminoasylum.shop, later redirected to a coupon page for a different seller. None of that tells a reader who is behind the current storefront, and the ownership statement, which names only an unnamed investment group, does not either. A research-use-only disclaimer is present.

The catalog is broad in a way that matters for a compliance-minded buyer. Alongside peptides, it lists SARMs, pro-hormones and items sold under the names of prescription drugs, which puts the storefront in a different category from a peptide-only supplier. Sample prices include a 30 mL T4 liquid at $24.99, a 1 mg IGF-LR3 at $59.99, PT-141 at $49.99, GC-1 at $114.99 and a 30 mL YK-11 liquid at $39.99. The record has no standalone BPC-157 price, so we cannot place the pricing against the market with any confidence.

Shipping terms are stated more clearly than most things on the site. Processing takes one to two business days, domestic standard delivery is quoted at five to seven business days, and international standard delivery at 10 to 21 business days, by USPS, UPS or FedEx. Free shipping starts at $500, the highest threshold among the suppliers we track. Payment methods are not stated. There is no published returns policy and no guarantee of any kind, so a buyer who receives a damaged or wrong item has no written terms to point to.

Bottom line

A brand that relaunches under a cloud has two ways to earn a second look: show who the new owner is, and show the documents. The current Amino Asylum does neither. It publishes an ownership statement and a compliance page, which is something, but it names no company, no person, no address, no phone, no email, no laboratory and no certificate, and the only independent test record available belongs to a predecessor whose samples failed more often than they passed. The catalog’s mix of SARMs, pro-hormones and prescription-named items adds a category risk that peptide-only suppliers do not carry. Until the operator names itself and publishes a certificate a reader can open, we would not order here, and we would not recommend that anyone else do so on the strength of the name alone.